New Straits Times [2 July, 2017]
“Hepatitis C: New hope for patients”
GHIT Fund [July, 2017]
Stakeholder interviews – Nathalie Strub-Wourgaft”
TagesWoche [27 May, 2017]
“Die UNO fordert alternative Finanzierungen für Medikamente” – “The UN demands alternative financing for medicines”
Sinchew.com [16 May, 2017]
“卫长：可从8万降至1200‧研发治C肝便宜新药” – “Wei Chang: from 80,000 down to 1200, R&D of new drugs for HCV”
IP Watch [21 April, 2017]
“Licence for a new Hepatitis treatment, with an eye to affordability”
November 1-3, 2017
São Paulo, Brazil
Francisco Viegas Neves da Silva, Regional Policy Advocacy Consultant, DNDi Latin America, presented on the DNDi strategy on access to hepatitis C treatment.
October 20-24, 2017
Washington DC, USA
Isabelle Andrieux-Meyer, Paediatric HIV/HCV Team Leader at DNDi, spoke at the HCV public health symposium.
Caracol RADIO [24 March, 2017]
“Expresidente Samper se convirtió en embajador de las Enfermedades Olvidadas” – “Former President appointed ambassador of neglected diseases”
Scienza e Farmaci [15 February, 2017]
“Come governare l’innovazione farmaceutica? La sfida è globale” – “How to govern pharmaceutical innovation? The challenge is global”
[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.
October 4-6, 2017
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.
September 26-29, 2017
DNDi Latin America’s Regional Policy Advocacy Consultant, Francisco Viegas, gave a presentation on innovation and access for neglected populations.
Ärzte Zeitung [30 January, 2017]
“London Declaration entfaltet ihre Wirkung” – “London Declaration develops its impact”
July 9-14, 2017
São Paulo, Brazil
Charles Mowbray, Head of Discovery, DNDi presented on drug discovery for neglected diseases.
The Malaysian Reserve [19 January, 2017]
“Doctors should be more involved in research”
Borneo Post Online [19 January, 2017]
“Health Ministry aims to lower treatment cost for hepatitis C”
April 22-25, 2017
DNDi participated in the event.
April 19-23, 2017
Amsterdam, The Netherlands
Isabelle Andrieux-Meyer, HIV/HCV Team Leader, DNDi took part in the event.
Our staff, partners, and stakeholders share their highlights from 2016.